APA (7th ed.) Citation

M, B., A, J., V, A., M, W., F, B., A, N., . . . M, Z. (2024). Phase I dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of an inhaled recombinant human ACE2. ERJ open research, 10(1), . https://doi.org/10.1183/23120541.00567-2023

Chicago Style (17th ed.) Citation

M, Bauer, et al. "Phase I Dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Inhaled Recombinant Human ACE2." ERJ Open Research 10, no. 1 (2024). https://doi.org/10.1183/23120541.00567-2023.

MLA (9th ed.) Citation

M, Bauer, et al. "Phase I Dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Inhaled Recombinant Human ACE2." ERJ Open Research, vol. 10, no. 1, 2024, https://doi.org/10.1183/23120541.00567-2023.